Chitosan Phonophresis on Cervical IN Smartphone Addicted Users

October 6 University

Status: Enrolling

Conditions: Cervical Pain

Treatments: Other: selected physical therapy exercise; Drug: Chitosan Phonophresis

Study type: Interventional

Funder types: Other

Identifiers

NCT06491992

O6U.PT.REC/024/002003

Details and patient eligibility

About

A phonophoresis-based drug delivery system is a synchronous approach to improve local drug penetration in neuromuscular diseases associated with neuronal damage, excruciating pain, and local inflammation. Chitosan, a semi-synthetic material, is obtained by partial deacetylation of chitin amines, resulting in copolymers of N-acetylglucosamine and N-glucosamine. Its use has been explored in various biomaterial and medical applications. Chitosan has emerged as a cost-effective, biocompatible, and biodegradable material with many desirable biological properties, improvement of homeostasis and antiviral potential. Chitosan was found to suppress pro-inflammatory cytokines and decreased peripheral nerve edema, the polycationic nature of chitosan allows it to absorb protons, which reduces inflammation and provides an analgesic effect.

Full description

The patients will randomly be divided into two equal groups; the control group which will receive the selected exercise program and the study group will receive the same exercise training program in addition to Chitosan Phonophresis, three times per week for four weeks.

Enrollment: 30 estimated patients

Sex: All

Ages: 16 to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Their age will be ranged from 16-18 years
• body mass index will be 26.58 kg/m2.
• used a smart phone for more than 1 year for at least 2 hours per day
• complaining of neck pain after using a smart phone, addiction to smart phone in accordance with the smart phone addiction scale (SAS)

Exclusion criteria

• any previous head and neck injuries or surgeries
• any congenital abnormalities or symptomatic deformity in either the cervical or the lumbar spine
• any uncorrected visual or auditory problems, dizziness, vertigo and headache
• any systematic diseases, any addiction to alcohol, any additive drugs and sedatives within 48 hours previous to tests
• body mass index of subjects over25 kg/m2.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

30 participants in 2 patient groups

study group

Experimental group

Description:

Chitosan Phonophresis intervention

Treatment:

Drug: Chitosan Phonophresis

Other: selected physical therapy exercise

control group

Experimental group

Description:

the selected exercise program

Treatment:

Other: selected physical therapy exercise